Biggest News Aggregation in the World
๐Ÿ“ฐ Single Dose News

Page 4 - Single Dose News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Single Dose. Real-time updates on events, politics, business and more.

Vertex and CRISPR Therapeutics to Present at the American Society of Hematology (ASH) Annual Meeting

- Oral presentation of encore clinical data from Phase 3 clinical trials of exa-cel -- Oral and poster presentations on quality-of-life impacts of sickle cell disease or transfusion-dependent beta-thalassemia and burden of hematopoietic stem cell transplant -BOSTON and ZUG, Switzerland--(BUSINESS WIRE)--Vertex Pharm...
United States United Kingdom City Of San Francisco Susan Kim Miroslava Minkova

Sermonix Pharmaceuticals Announces Poster Presentation on Phase 1 Ethnobridging Study of Lasofoxifene at the 12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research — Translating Knowledge Into Practice

Sermonix Pharmaceuticals Announces Poster Presentation on Phase 1 Ethnobridging Study of Lasofoxifene at the 12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research โ€” Translating Knowledge Into Practice - read this article along with other careers information, tips and advice on BioSpace
United States Paul Plourde Miriam Portman Simon Jenkins David Portman Elizabeth Attias

Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study

Katrine Finderup Nielsen and colleagues investigate vaccine effectiveness against SARS-CoV-2 reinfection, COVID-19 related hospitalization and COVID-19 related death, in previously infected individuals in Denmark.
United States United Kingdom Vaxzevria Chadox Jamesg Beeson Danish Data Protection Agency International Classification Of Diseases
Source: plos.org

USFDA approval for Alembic's Ketorolac Tromethamine Inj

Uniindia: Mumbai, Nov 3 (UNI) Pharma major, Alembic Pharma on Thursday said it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 mL (30 mg/mL) Single Dose Vials.
Ketorolac Tromethamine Ketorolac Tromethamine Injmumbai Us Food Drug Administration Roche Palo Alto Alembic Pharma Drug Administration

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science